# Nuvation Bio Inc.: filings

NUVB · NYSE · CIK 1811063 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nuvb.md) · [Financials](/companies/nuvb/financials.md) · [Filings](/companies/nuvb/filings.md) · [Insiders](/companies/nuvb/insiders.md)

## Reports and events: 103 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 146, 8-K 59, 3 31, 10-Q 19, 144 17, 424B3 9, SC 13G/A 9, SC 13G 8, 425 7, 4/A 7, CORRESP 7, S-8 7, UPLOAD 7, 10-K 6, EFFECT 6, DEF 14A 5, ARS 4, S-4/A 3, SC 13D 3, SC 13D/A 3, SCHEDULE 13G/A 3, 10-K/A 2, 25-NSE 2, 424B5 2, 8-K/A 2, POS AM 2, PRER14A 2, S-1 2, S-1/A 2, SEC STAFF LETTER 2, 305B2 1, 424B4 1, 8-A12B 1, CERT 1, DEFA14A 1, DEFR14A 1, DRS 1, FWP 1, PRE 14A 1, S-3 1, S-3ASR 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 07:30 ET | [8-K](/filings/0001193125-26-336751.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336751 |
| 2026-08-06 | 06:55 ET | [10-Q](/filings/0001193125-26-336646.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336646 |
| 2026-07-06 | 17:15 ET | [8-K](/filings/0001193125-26-296398.md) | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-296398 |
| 2026-06-30 | 17:17 ET | [8-K](/filings/0001193125-26-290823.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-290823 |
| 2026-05-27 | 16:16 ET | [8-K](/filings/0001193125-26-241922.md) | 5.07 Shareholder vote results | 0001193125-26-241922 |
| 2026-05-04 | 16:21 ET | [8-K](/filings/0001193125-26-204056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204056 |
| 2026-05-04 | 16:06 ET | [10-Q](/filings/0001193125-26-203964.md) | Quarterly report, period 2026-03-31 | 0001193125-26-203964 |
| 2026-04-10 | 11:23 ET | [DEF 14A](/filings/0001140361-26-014157.md) | Proxy statement, period 2026-05-21 | 0001140361-26-014157 |
| 2026-03-02 | 16:49 ET | [10-K](/filings/0001193125-26-085584.md) | Annual report, period 2025-12-31 | 0001193125-26-085584 |
| 2026-03-02 | 16:22 ET | [8-K](/filings/0001193125-26-085474.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-085474 |
| 2026-01-12 | 08:07 ET | [8-K](/filings/0001193125-26-009826.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009826 |
| 2025-11-26 | 08:34 ET | [8-K](/filings/0001193125-25-298551.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-298551 |
| 2025-11-17 | 17:31 ET | [8-K](/filings/0001193125-25-284845.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-284845 |
| 2025-11-03 | 16:22 ET | [10-Q](/filings/0001193125-25-262605.md) | Quarterly report, period 2025-09-30 | 0001193125-25-262605 |
| 2025-11-03 | 16:15 ET | [8-K](/filings/0001193125-25-262576.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-262576 |
| 2025-08-07 | 09:07 ET | [10-Q](/filings/0000950170-25-104626.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104626 |
| 2025-08-07 | 07:30 ET | [8-K](/filings/0001193125-25-174954.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174954 |
| 2025-06-11 | 16:24 ET | [8-K](/filings/0001193125-25-139164.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139164 |
| 2025-05-23 | 14:21 ET | [8-K](/filings/0001193125-25-125763.md) | 5.07 Shareholder vote results | 0001193125-25-125763 |
| 2025-05-07 | 16:20 ET | [10-Q](/filings/0000950170-25-065712.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065712 |
| 2025-05-07 | 16:15 ET | [8-K](/filings/0001193125-25-114908.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-114908 |
| 2025-04-08 | 16:45 ET | [DEF 14A](/filings/0001140361-25-012864.md) | Proxy statement, period 2025-05-21 | 0001140361-25-012864 |
| 2025-03-25 | 09:05 ET | [8-K](/filings/0001193125-25-062031.md) | 1.01 Entry into a material agreement | 0001193125-25-062031 |
| 2025-03-06 | 17:13 ET | [10-K](/filings/0000950170-25-034903.md) | Annual report, period 2024-12-31 | 0000950170-25-034903 |
| 2025-03-06 | 17:12 ET | [8-K](/filings/0001193125-25-048529.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-048529 |
| 2025-03-05 | 16:04 ET | [8-K](/filings/0001193125-25-047165.md) | 1.01 Entry into a material agreement | 0001193125-25-047165 |
| 2025-03-04 | 16:01 ET | [8-K](/filings/0001193125-25-045568.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-045568 |
| 2025-02-12 | 16:05 ET | [8-K](/filings/0001193125-25-025099.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-025099 |
| 2024-11-06 | 16:43 ET | [8-K](/filings/0001193125-24-252153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252153 |
| 2024-11-06 | 16:41 ET | [10-Q](/filings/0000950170-24-122402.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122402 |
| 2024-10-18 | 16:15 ET | [SC 13D/A](/filings/0001193125-24-239642.md) | Ownership report, active investor, amended | 0001193125-24-239642 |
| 2024-10-07 | 16:10 ET | [8-K](/filings/0001193125-24-233794.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-233794 |
| 2024-09-10 | 16:51 ET | [SC 13D](/filings/0001104659-24-098630.md) | Ownership report, active investor | 0001104659-24-098630 |
| 2024-09-05 | 16:35 ET | [8-K](/filings/0001193125-24-214241.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-24-214241 |
| 2024-08-05 | 08:44 ET | [10-Q](/filings/0000950170-24-090347.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090347 |
| 2024-08-05 | 08:37 ET | [8-K](/filings/0001193125-24-193412.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-193412 |
| 2024-07-30 | 16:01 ET | [DEF 14A](/filings/0001193125-24-188838.md) | Proxy statement, period 2024-09-03 | 0001193125-24-188838 |
| 2024-06-20 | 17:26 ET | [8-K/A](/filings/0001193125-24-164595.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-164595 |
| 2024-05-14 | 16:28 ET | [10-Q](/filings/0000950170-24-059622.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059622 |
| 2024-05-14 | 16:20 ET | [8-K](/filings/0001193125-24-138263.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-138263 |
| 2024-04-26 | 16:13 ET | [10-K/A](/filings/0000950170-24-049137.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-049137 |
| 2024-04-10 | 16:06 ET | [8-K](/filings/0001193125-24-091875.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-091875 |
| 2024-03-26 | 20:15 ET | [SC 13D/A](/filings/0001193125-24-077868.md) | Ownership report, active investor, amended | 0001193125-24-077868 |
| 2024-03-25 | 07:06 ET | [8-K](/filings/0001193125-24-075908.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-075908 |
| 2024-02-29 | 17:06 ET | [10-K](/filings/0000950170-24-023247.md) | Annual report, period 2023-12-31 | 0000950170-24-023247 |
| 2024-02-29 | 16:48 ET | [8-K](/filings/0001193125-24-053575.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-053575 |
| 2024-01-08 | 16:17 ET | [8-K](/filings/0001193125-24-004426.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-004426 |
| 2023-12-14 | 16:02 ET | [8-K](/filings/0001193125-23-295446.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295446 |
| 2023-11-27 | 16:01 ET | [8-K](/filings/0001193125-23-283346.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-283346 |
| 2023-11-13 | 16:11 ET | [8-K](/filings/0001193125-23-276021.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-276021 |

Page 1 of 3. [Older](/companies/nuvb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.